10X Genomics
Quy Xiao Xuan Lin is a highly skilled bioinformatician with significant expertise in computational biology and bioinformatics. Currently serving as Staff Scientist and previously as Senior Scientist in Applied Bioinformatics at 10x Genomics since January 2022, Quy has contributed to advanced projects including the SCAN COVID-19 initiative under the mentorship of Shyam Prabhakar. Prior experience includes a position as Computational Biologist at the Genome Institute of Singapore from June 2020 to January 2022, and a Research Fellow at the National University of Singapore from December 2019 to May 2020. Quy holds a Doctor of Philosophy (Ph.D.) in Computational Biology from the National University of Singapore (2016-2020) and has an educational background in medicine with a Bachelor of Medicine from Zhejiang University (2010-2015) and further studies at UCLA (2014-2015).
This person is not in any offices
10X Genomics
18 followers
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend, and have been cited in over 3,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,200 issued patents and patent applications.